OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

METTL14 is decreased and regulates m6A modification of α‐synuclein in Parkinson's disease
Honghu He, Qinxin Zhang, Jiajia Liao, et al.
Journal of Neurochemistry (2023) Vol. 166, Iss. 3, pp. 609-622
Closed Access | Times Cited: 14

Showing 14 citing articles:

Regulatory roles of N6-methyladenosine (m6A) methylation in RNA processing and non-communicable diseases
Faiz Ali Khan, Bernard Nsengimana, Usman Ayub Awan, et al.
Cancer Gene Therapy (2024)
Closed Access | Times Cited: 9

Emerging Roles for DNA 6mA and RNA m6A Methylation in Mammalian Genome
Leijie Xie, Xiaosong Zhang, Jiaxiang Xie, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13897-13897
Open Access | Times Cited: 11

Neurodegenerative diseases: Epigenetic regulatory mechanisms and therapeutic potential
Jifang Men, Xinyue Wang, Yumin Zhou, et al.
Cellular Signalling (2025) Vol. 131, pp. 111715-111715
Closed Access

Emerging importance of m6A modification in liver cancer and its potential therapeutic role
Tao Chen, Wufei Ye, Songsen Gao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189299-189299
Closed Access

Edge of RNA m6A modification on LINE-1 retrotransposons in central nervous system: merely a transcriptional control?
Amit Sharma, Tikam Chand Dakal, Ingo Schmidt‐Wolf, et al.
Epigenomics (2025), pp. 1-3
Closed Access

Emerging Roles and Mechanisms of RNA Modifications in Neurodegenerative Diseases and Glioma
Ami Kobayashi, Yosuke Kitagawa, Ali M. Nasser, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 457-457
Open Access | Times Cited: 3

N6-methyladenosine demethylase FTO regulates neuronal oxidative stress via YTHDC1-ATF3 axis in arsenic-induced cognitive dysfunction
Lixiao Zhou, Renjie Li, Fu Wang, et al.
Journal of Hazardous Materials (2024) Vol. 480, pp. 135736-135736
Closed Access | Times Cited: 2

Potential role of N6-methyladenosine modification in the development of Parkinson’s disease
Jiale Zhou, Yang Han, Ruizhe Hou
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 4

The role of N6-methyladenosine modification in neurodegenerative diseases
Junzhu Song, Sen Yan
Ageing and Neurodegenerative Diseases (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 1

Small molecule activation of m6A mRNA methylation as a novel approach for neuroprotection
Li-Ying Yu, Simona Selberg, Indrek Teino, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3

Circadian rhythm in neurodegenerative disease: the role of RNA modifications and potential application of RNA-based therapeutics
G H Jiang, Lin Yuan, Xiaoyue Liu, et al.
Ageing and Neurodegenerative Diseases (2024) Vol. 4, Iss. 3
Open Access

The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies
Muhammad Abu Talha Safdar Hashmi, Hooriya Fatima, Sadia Ahmad, et al.
Ibrain (2024) Vol. 10, Iss. 4, pp. 395-426
Open Access

Page 1

Scroll to top